Analyze Diet
Journal of equine veterinary science2019; 75; 30-34; doi: 10.1016/j.jevs.2018.12.015

Influence of Incubation Time and Incubation Tube on the Cytokine and Growth Factor Concentrations of Autologous Conditioned Serum in Horses.

Abstract: Autologous conditioned serum (ACS) is commonly used for the treatment of human and equine osteoarthritis (OA). The objective of this study was to investigate the influence of incubation time and incubation tube on concentrations of interleukin-1 receptor antagonist (IL-1ra), interleukin-1 beta (IL-1β), and insulin-like growth factor-1 (IGF-1) in ACS of horses with and without OA. Blood samples of 7 control horses and 6 horses with naturally occurring OA were obtained. The concentration of serum IL-1ra, IL-1β, and IGF-1 was determined after 12, 24, and 36 hours of incubation using commercial serum vacutainer glass tubes (incubated serum [IS]) or a specific equine ACS system. There was no significant difference in IL-1ra, IL-1β, and IGF-1 concentrations between IS and ACS samples detectable at 24 or 36 hours of incubation. The ACS of horses with OA and control horses did not contain significantly different cytokine or growth factor concentrations. In conclusion, an incubation time exceeding 24 hours does not lead to a significant increase in cytokine and growth factor concentrations in equine ACS. Incubation of whole blood in commercial serum glass tubes has similar effects on the IL-1ra, IL-1β, and IGF-1 concentrations when compared with the incubation in specialized equine ACS kits. Interleukin-1 receptor antagonist, IL-1β, and IGF-1 concentrations in ACS of OA horses is not significantly increased when compared with control horses.
Publication Date: 2019-01-08 PubMed ID: 31002089DOI: 10.1016/j.jevs.2018.12.015Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article aims to determine whether the amount of time that autologous conditioned serum (ACS) from horses incubates, as well as the type of tube used for incubation, affects the concentrations of certain proteins within the serum. The researchers found that extending the incubation period past 24 hours, or changing the type of incubation tube, does not significantly alter the concentrations of these proteins.

Objective and Process of the Study

  • The research focused on testing the levels of interleukin-1 receptor antagonist (IL-1ra), interleukin-1 beta (IL-1β), and insulin-like growth factor-1 (IGF-1) in ACS of horses. These substances are known to have an influence on osteoarthritis (OA), a common disease amongst horses.
  • Testing was conducted on both control horses, and those naturally suffering from OA, to see if there was a difference between the two groups in terms of protein concentration in the ACS.
  • The blood samples taken from these horses were split into parts that were incubated for 12, 24, and 36 hours.
  • Additionally, the researchers compared results from traditional serum vacutainer glass tubes and a specialized equine ACS system.

Results and Conclusions

  • The research concluded that increasing the incubation time beyond 24 hours did not significantly increase the ACS concentrations of IL-1ra, IL-1β, and IGF-1 in horses.
  • Similarly, using different types of incubation tubes, whether commercial serum glass or specialized equine ACS systems, did not greatly alter the concentrations of these proteins.
  • The study also found that these concentrations were not significantly higher in ACS from horses with OA, compared to controls. This suggests that the presence of OA does not mean higher concentrations of these proteins in the ACS.

This research helps to clarify how the preparation of ACS for treatment affects its protein concentrations, and verifies that potential effects of osteoarthritis on the protein concentration in ACS are minimal.

Cite This Article

APA
Lasarzik de Ascurra J, Ehrle A, Einspanier R, Lischer C. (2019). Influence of Incubation Time and Incubation Tube on the Cytokine and Growth Factor Concentrations of Autologous Conditioned Serum in Horses. J Equine Vet Sci, 75, 30-34. https://doi.org/10.1016/j.jevs.2018.12.015

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 75
Pages: 30-34
PII: S0737-0806(18)30612-9

Researcher Affiliations

Lasarzik de Ascurra, Juliane
  • Equine Clinic, Free University of Berlin, Berlin, Germany. Electronic address: juliane.lasarzik@gmail.com.
Ehrle, Anna
  • Equine Clinic, Free University of Berlin, Berlin, Germany.
Einspanier, Ralf
  • Institute of Veterinary Biochemistry, Free University of Berlin, Berlin, Germany.
Lischer, Christoph
  • Equine Clinic, Free University of Berlin, Berlin, Germany.

MeSH Terms

  • Animals
  • Cytokines
  • Horses
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Osteoarthritis / veterinary
  • Serum

Citations

This article has been cited 9 times.
  1. Löfgren M, Ekman S, Ekholm J, Engström M, Fjordbakk CT, Svala E, Holm Forsström K, Lindahl A, Skiöldebrand E. Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants. Equine Vet J 2023 Mar;55(2):325-335.
    doi: 10.1111/evj.13582pubmed: 35514185google scholar: lookup
  2. Hale J, Hughes K, Hall S, Labens R. Effects of Production Method and Repeated Freeze Thaw Cycles on Cytokine Concentrations and Microbial Contamination in Equine Autologous Conditioned Serum. Front Vet Sci 2021;8:759828.
    doi: 10.3389/fvets.2021.759828pubmed: 34901249google scholar: lookup
  3. Camargo Garbin L, Morris MJ. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses. Front Vet Sci 2021;8:602978.
    doi: 10.3389/fvets.2021.602978pubmed: 33681323google scholar: lookup
  4. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  5. Bauer C, Kern D, Petkin K, Nehrer S. Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum. J Clin Med 2026 Jan 27;15(3).
    doi: 10.3390/jcm15031014pubmed: 41682693google scholar: lookup
  6. Yuan C, Ang SP, Hasoon JJ, Tolba R, Ruan QZ, Lam CM, Lo Bianco G, Christo PJ, Robinson CL. Dual-Action Regenerative Therapies: Regeneration and Antimicrobial Effects of Platelet- and Marrow-Derived Biologics. Biomedicines 2025 Nov 20;13(11).
    doi: 10.3390/biomedicines13112832pubmed: 41301922google scholar: lookup
  7. Roth SP, Liso G, Brehm W, Wagner B, Schnabel CL, Troillet A. Selected cytokine and chemokine concentrations in equine autologous conditioned serum are similar under defined and practically relevant storage conditions. Front Vet Sci 2025;12:1588240.
    doi: 10.3389/fvets.2025.1588240pubmed: 40496923google scholar: lookup
  8. Usimaki A, Ciamillo SA, Barot D, Linardi RL, Engiles JB, Ortved KF. Single injection of intra-articular autologous protein solution in horses with acute interleukin-1B-induced synovitis decreases joint pathology scores. Equine Vet J 2025 May;57(3):806-816.
    doi: 10.1111/evj.14203pubmed: 39051479google scholar: lookup
  9. Della Tommasa S, Brehm W, Farì G, Bernetti A, Imperante A. Use of Autologous Conditioned Serum (ACS) for Osteoarthritis Treatment in Horses: A Systematic Review of Clinical Data. Vet Sci 2023 Dec 18;10(12).
    doi: 10.3390/vetsci10120707pubmed: 38133258google scholar: lookup